| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
|---|
| Outline of Final Research Achievements |
We conducted health economic evaluation to estimate the cost-effectiveness of the therapy for osteoporosis. At first, we summarized the problem of the medical economic evaluation reported in the field of osteoporosis through a literature review. We also developed a model to express the prognosis of the osteoporosis patients and examined its validity. Based on the developed model, we performed a cost-effectiveness analysis of the treatment for primary or second fracture prevention. Furthermore, we estimated the medical cost due to osteoporotic fracture by using the receipt data of the osteoporosis patients.
Through a series of approaches, we arranged a technical problem in the cost-effectiveness analysis of the osteoporosis treatment.
|
